Skip to main content
Market intelligence
GILDHealthcare

Gilead Sciences, Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 20, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 20, 2026Jeffrey BluestoneCorporate insiderSale5,000$145.02$725,078
Aug 17, 2026Johanna MercierChief Comm & Corp Aff OfficerSale28,000$137.64$3,853,909
Aug 17, 2026Andrew D DickinsonChief Financial OfficerSale3,000$138.36$415,080